Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Dubuisson

Showing results (201-210 of 233) with videos related to

Pageof 24
Sort By:
Journal of Virology|July 15, 2016
Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusThibaut Vausselin, Karin Séron, Muriel Lavie, et al.
Viruses|January 22, 2022
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy InhibitionEloïne Bestion, Keivan Zandi, Sandrine Belouzard, et al.
Journal of Virology|March 2, 2018
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus EntryLaura Riva, Ok-Ryul Song, Jannick Prentoe, et al.
Journal of Virology|June 5, 2015
New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin ALucie Fénéant, Julie Potel, Catherine François, et al.
Plos One|August 14, 2013
Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virusFrancois Helle, Etienne Brochot, Carole Fournier, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsKoen Vercauteren, Naomi Van Den Eede, Ahmed Atef Mesalam, et al.
Plos One|September 20, 2019
Correction: Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C VirusFrancois Helle, Etienne Brochot, Carole Fournier, et al.
Plos One|October 31, 2014
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinReem R Al Olaby, Laurence Cocquerel, Adam Zemla, et al.
European Journal of Medicinal Chemistry|October 30, 2025
A new chemotype that opens the S2∗ pocket of the 3CL protease exhibits antiviral activity against SARS-CoV-2Laura Mourot, Fatima-Zahra Chaibi, Nour Bou-Karroum, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral ReplicationSantseharay Ramirez, Carlota Fernandez-Antunez, Andrea Galli, et al.
Pageof 24

Showing results (201-210 of 233) with videos related to

Sort By:
Pageof 24
Journal of Virology|July 15, 2016
Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusThibaut Vausselin, Karin Séron, Muriel Lavie, et al.
Viruses|January 22, 2022
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy InhibitionEloïne Bestion, Keivan Zandi, Sandrine Belouzard, et al.
Journal of Virology|March 2, 2018
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus EntryLaura Riva, Ok-Ryul Song, Jannick Prentoe, et al.
Journal of Virology|June 5, 2015
New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin ALucie Fénéant, Julie Potel, Catherine François, et al.
Plos One|August 14, 2013
Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virusFrancois Helle, Etienne Brochot, Carole Fournier, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agentsKoen Vercauteren, Naomi Van Den Eede, Ahmed Atef Mesalam, et al.
Plos One|September 20, 2019
Correction: Permissivity of Primary Human Hepatocytes and Different Hepatoma Cell Lines to Cell Culture Adapted Hepatitis C VirusFrancois Helle, Etienne Brochot, Carole Fournier, et al.
Plos One|October 31, 2014
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinReem R Al Olaby, Laurence Cocquerel, Adam Zemla, et al.
European Journal of Medicinal Chemistry|October 30, 2025
A new chemotype that opens the S2∗ pocket of the 3CL protease exhibits antiviral activity against SARS-CoV-2Laura Mourot, Fatima-Zahra Chaibi, Nour Bou-Karroum, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral ReplicationSantseharay Ramirez, Carlota Fernandez-Antunez, Andrea Galli, et al.
Pageof 24